Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer
Alessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 5, pp. 547-554
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 4, pp. 343-350
Closed Access | Times Cited: 101
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100354-100354
Open Access | Times Cited: 88
New trends in diagnosis and management of gallbladder carcinoma
Efstathios Pavlidis, I. Galanis, T. Pavlidis
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 13-29
Open Access | Times Cited: 11
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
Tianmei Zeng, Guang Yang, Cheng Lou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy
Yanjun Sun, Jun-feng Gong, Zhuang Li, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 3, pp. 278-291
Closed Access | Times Cited: 6
Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
Sandra Kang, Bassel F. El‐Rayes, Mehmet Akce
Cancers (2022) Vol. 14, Iss. 7, pp. 1748-1748
Open Access | Times Cited: 24
Artificial intelligence for automatic diagnosis and pleomorphic morphological characterization of malignant biliary strictures using digital cholangioscopy
Miguel Mascarenhas, Maria João Almeida, Mariano González-Haba, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report
Hailing Yu, Tan Deng, Hongbing Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100356-100356
Open Access | Times Cited: 25
Clinical epidemiology of gallbladder cancer in North-Central India and association of immunological markers, NLR, MLR and PLR in the diagnostic/prognostic prediction of GBC
Jyotsna Singh, Durgesh Shukla, Sanjiv Gupta, et al.
Cancer Treatment and Research Communications (2021) Vol. 28, pp. 100431-100431
Open Access | Times Cited: 21
Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma
Tadahisa Inoue, Itaru Naitoh, Rena Kitano, et al.
Current Oncology (2022) Vol. 29, Iss. 4, pp. 2240-2251
Open Access | Times Cited: 14
miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4
Jiaqiang Deng, Huani Wang, Yutong Liang, et al.
Cellular Signalling (2022) Vol. 101, pp. 110517-110517
Closed Access | Times Cited: 14
The role of lymph node dissection in intrahepatic cholangiocarcinoma: a multicenter retrospective study
Hanjie Hu, Gang Xu, Shunda Du, et al.
BMC Surgery (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Peroral Cholangioscopy-Guided Targeted Biopsy versus Conventional Endoscopic Transpapillary Forceps Biopsy for Biliary Stricture with Suspected Bile Duct Cancer
Katsunori Sekine, Ichiro Yasuda, Shinpei Doi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 289-289
Open Access | Times Cited: 13
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers
Jianan Jin, Haibo Mou, Yibin Zhou, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Current and emerging immunotherapeutic approaches for biliary tract cancers
Zhen-gang Yuan, Tianmei Zeng, Chen‐jie Tao
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 440-449
Closed Access | Times Cited: 11
Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors
Alessandro Rizzo
Medicina (2021) Vol. 57, Iss. 5, pp. 458-458
Open Access | Times Cited: 13
Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis
Yao Jin, Jiayan Wei, Yiming Weng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review
Zhi-Qing Duan, Yinuo Zhang, Yajie Tang, et al.
Translational Oncology (2022) Vol. 20, pp. 101414-101414
Open Access | Times Cited: 9
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future
Alessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, et al.
Current Oncology (2022) Vol. 29, Iss. 2, pp. 551-564
Open Access | Times Cited: 8
Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma
F. D’Amico, Claudia Mescoli, Silvia Caregari, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1680-1680
Open Access | Times Cited: 8
Clinical and socioeconomic determinants of survival in biliary tract adenocarcinomas
Laura Sahyoun, Kay Chen, Cynthia Tsay, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1374-1383
Open Access | Times Cited: 1
Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment
Fei Pei, Tao Zhen, Lu Qi, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The effectiveness of adequate lymphadenectomy in radically-resected cases with pathologically-confirmed node-negative biliary tract cancers: A SEER-based retrospective cohort study
Tian‐Run Lv, Hongjun Lin, Hai‐Jie Hu, et al.
Current Problems in Surgery (2024) Vol. 61, Iss. 8, pp. 101500-101500
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top